<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mismatch repair (MMR) malfunction causes the accumulation of mismatches in the genome leading to genomic instability and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The inactivation of an MMR gene (MSH2, MSH6, MLH1, or PMS2) with an inherited mutation causes <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (LS), a dominant susceptibility to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MMR gene variants of uncertain significance (VUS) may be pathogenic mutations, which cause LS, may result in moderately increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risks, or may be harmless polymorphisms </plain></SENT>
<SENT sid="3" pm="."><plain>Our study suggests that an inherited MMR VUS individually assessed as proficient may, however, in a pair with another MMR VUS found in the same <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patient have a concomitant contribution to the MMR deficiency </plain></SENT>
<SENT sid="4" pm="."><plain>Here, eight pairs of MMR gene variants found in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients were functionally analyzed in an in vitro MMR assay </plain></SENT>
<SENT sid="5" pm="."><plain>Although the other pairs do not suggest a compound deficiency, the MSH2 VUS pair c.380A&gt;G/c.982G&gt;C (p.Asn127Ser/p.Ala328Pro), which nearly halves the repair capability of the <z:mp ids='MP_0002169'>wild-type</z:mp> MSH2 protein, is presumed to increase the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk considerably </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, two MSH6 variants, c.1304T&gt;C (p.Leu435Pro) and c.1754T&gt;C (p.Leu585Pro), were shown to be MMR deficient </plain></SENT>
<SENT sid="7" pm="."><plain>The role of one of the most frequently reported MMR gene VUS, MSH2 c.380A&gt;G (p.Asn127Ser), is especially interesting because its concomitant defect with another variant could finally explain its recurrent occurrence in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>